Randomized open trial comparing 2-dose regimens of the human papillomavirus 16/18 as04-adjuvanted vaccine in girls aged 9-14 years versus a 3-dose regimen in women aged 15-25 years
- Thanyawee Puthanakit*
- , Li Min Huang
- , Cheng Hsun Chiu
- , Ren Bin Tang
- , Tino F. Schwarz
- , Susanna Esposito
- , Louise Frenette
- , Carlo Giaquinto
- , Shelly McNeil
- , Paul Rheault
- , Paolo Durando
- , Michael Horn
- , Maximilian Klar
- , Sylviane Poncelet
- , Stéphanie De Simoni
- , Damien Friel
- , Benoit De Muynck
- , Pemmaraju V. Suryakiran
- , Marjan Hezareh
- , Dominique Descamps
*Corresponding author for this work
- Chulalongkorn University
- National Taiwan University
- Chang Gung University
- Cheng Hsin General Hospital
- Central Laboratory and Vaccination Centre
- University of Milan
- QandT Research Incorporated
- Azienda Ospedaliera di Padova
- Dalhousie University
- Medicor Research Inc
- University of Genoa
- Pediatric Office Dr. Med. Michael Horn
- University of Freiburg
- GlaxoSmithKline
Research output: Contribution to journal › Journal Article › peer-review
51
Scopus
citations